IPILIMUMAB for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for IPILIMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,710 | 10.2% | 3,709 | 285 |
| Malignant neoplasm progression | 3,296 | 9.0% | 1,570 | 1,538 |
| Diarrhoea | 2,557 | 7.0% | 305 | 1,643 |
| Off label use | 2,097 | 5.7% | 528 | 731 |
| Colitis | 1,988 | 5.4% | 293 | 1,229 |
| Pyrexia | 1,796 | 4.9% | 237 | 1,336 |
| Rash | 1,556 | 4.3% | 162 | 694 |
| Fatigue | 1,447 | 4.0% | 176 | 776 |
| Intentional product use issue | 1,329 | 3.6% | 563 | 347 |
| Nausea | 1,169 | 3.2% | 139 | 773 |
| Decreased appetite | 990 | 2.7% | 136 | 665 |
| Immune-mediated enterocolitis | 988 | 2.7% | 73 | 504 |
| Hypophysitis | 981 | 2.7% | 61 | 515 |
| Dyspnoea | 906 | 2.5% | 165 | 651 |
| Pneumonitis | 891 | 2.4% | 220 | 560 |
Other Indications for IPILIMUMAB
Malignant melanoma (8,903)
Product used for unknown indication (4,980)
Metastatic malignant melanoma (4,430)
Non-small cell lung cancer (2,987)
Renal cell carcinoma (2,585)
Metastatic renal cell carcinoma (1,826)
Non-small cell lung cancer recurrent (1,089)
Lung neoplasm malignant (530)
Small cell lung cancer (474)
Pleural mesothelioma malignant (473)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)